CONCLUSIONS
toxicities
Weekly schedule of cisplatin and nab‐paclitaxel combined with concurrent radiotherapy showed manageable toxicities and promising antitumor effect in patients with locally advanced ESCC. The recommended dose of nab‐paclitaxel for further studies is 75 mg/m